CVLB News and Press, Conversion Labs Inc From 04/21/20

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited revenue of approximately $4.3 million for the first quarter ended March 31, 2020, up 60% compared to the same year-ago p...

NEW YORK, April 14, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed Dr. Jeremy Fine , a noted expert in internal medicine, to its medical advisory board . Dr. Fine will be involved in guidi...

Conversion Labs ( OTCQB:CVLB ): Q4 GAAP EPS of -$0.01. Revenue of $3.94M (+80.7% Y/Y) Press Release More news on: Conversion Labs, Inc., Earnings news and commentary, Consumer stocks news, ,

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the fourth quarter and full year ended December 31, 2019. Quarterly comparisons are to the same year-ago quarter. Fin...

NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received FDA 510(k) clearance for its new hair regrowth product, the Shapiro MD Laser Hair Restoration Device. “This innovative, easy...

NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, is demonstrating its support for those leading the fight against COVID-19 and those diagnosed with the virus by giving away 10,000 bottles of its INR...

NEW YORK, March 19, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its long-awaited new telemedicine brand, SOSRx . SOSRx is designed to deliver specially formulated combinations of prescr...

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, is on track for a big leap in revenue growth this year due to some clear market foresight and a strategic decision to enter the telemedicine marke...

NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.  (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, issued its 2020 shareholder letter today in which management highlighted the company’s strong growth since its transition to a direct-to-con...

NEW YORK, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited net sales for the fourth quarter and full year ended December 31, 2019. For the fourth quarter of 2019, the company ex...